Authors,Author(s) ID,Title,Year,Source tittle,Cited by,DOI,Country,Document Type,City,Access Type,aggregationType,EID
Parkkila S.,,Carbonic anhydrase II. A novel biomarker for gastrointestinal stromal tumors,2010,Modern Pathology,61,10.1038/modpathol.2009.189,Finland;Finland,Article,Tampere;Tampere,1,Journal,2-s2.0-77952009344
Bauer S.,,Proapoptotic activity of bortezomib in gastrointestinal stromal tumor cells,2010,Cancer Research,32,10.1158/0008-5472.CAN-09-1449,Germany,Article,Essen,1,Journal,2-s2.0-75149160967
Zhang L.,,"Gastric stromal tumors in carney triad are different clinically, pathologically, and behaviorally from sporadic gastric gastrointestinal stromal tumors: Findings in 104 cases",2010,American Journal of Surgical Pathology,141,10.1097/PAS.0b013e3181c20f4f,United States,Article,Rochester,0,Journal,2-s2.0-73949152219
Hostein I.,,BRAF mutation status in gastrointestinal stromal tumors,2010,American Journal of Clinical Pathology,149,10.1309/AJCPPCKGA2QGBJ1R,France,Article,Bordeaux,1,Journal,2-s2.0-73949094832
Pantaleo M.A.,,Insulin-like growth factor 1 receptor expression in wild-type GISTs: A potential novel therapeutic target,2009,International Journal of Cancer,59,10.1002/ijc.24595,Italy,Article,Bologna,0,Journal,2-s2.0-72449212435
Türköz H.,,Cyclooxygenase-2 expression and connection with tumor recurrence and histopathologic parameters in gastrointestinal stromal tumors,2009,APMIS,4,10.1111/j.1600-0463.2009.02537.x,Turkey,Article,Istanbul,0,Journal,2-s2.0-70350341013
Gold J.,,Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localised primary gastrointestinal stromal tumour: a retrospective analysis,2009,The Lancet Oncology,308,10.1016/S1470-2045(09)70242-6,United States;United States,Article,Boston;New York,0,Journal,2-s2.0-71449088757
Wei Y.,,Ezrin overexpression in gastrointestinal stromal tumors: An independent adverse prognosticator associated with the non-gastric location,2009,Modern Pathology,23,10.1038/modpathol.2009.107,Taiwan,Article,Taoyuan,1,Journal,2-s2.0-70349673599
Belinsky M.,,High density DNA array analysis reveals distinct genomic profiles in a subset of gastrointestinal stromal tumors,2009,Genes Chromosomes and Cancer,33,10.1002/gcc.20689,United States,Article,Philadelphia,0,Journal,2-s2.0-70349337585
Martinho O.,,Loss of RKIP expression is associated with poor survival in GISTs,2009,Virchows Archiv,50,10.1007/s00428-009-0821-z,Portugal,Article,Braga,0,Journal,2-s2.0-70349285960
Mühlenberg T.,,"Inhibitors of deacetylases suppress oncogenic KIT signaling, acetylate HSP90, and induce apoptosis in gastrointestinal stromal tumors",2009,Cancer Research,63,10.1158/0008-5472.CAN-08-4004,Germany,Article,Essen,1,Journal,2-s2.0-70149091271
Montemurro M.,,Nilotinib in the treatment of advanced gastrointestinal stromal tumours resistant to both imatinib and sunitinib,2009,European Journal of Cancer,112,10.1016/j.ejca.2009.04.030,Switzerland,Article,Lausanne,0,Journal,2-s2.0-68949174991
Miettinen M.,,DOG1 antibody in the differential diagnosis of gastrointestinal stromal tumors: A study of 1840 cases,2009,American Journal of Surgical Pathology,283,10.1097/PAS.0b013e3181a90e1a,United States,Article,"Washington, D.C.",0,Journal,2-s2.0-70249090434
Agaimy A.,,Multiple sporadic gastrointestinal stromal tumours arising at different gastrointestinal sites: Pattern of involvement of the muscularis propria as a clue to independent primary GISTs,2009,Virchows Archiv,27,10.1007/s00428-009-0803-1,Germany,Article,Erlangen,0,Journal,2-s2.0-69049092600
Lasota J.,,"Gain-of-function PDGFRA mutations, earlier reported in gastrointestinal stromal tumors, are common in small intestinal inflammatory fibroid polyps. A study of 60 cases",2009,Modern Pathology,55,10.1038/modpathol.2009.62,United States,Article,"Washington, D.C.",1,Journal,2-s2.0-68249086826
Woodall C.,,An evaluation of 2537 gastrointestinal stromal tumors for a proposed clinical staging system,2009,Archives of Surgery,76,10.1001/archsurg.2009.108,United States,Article,Louisville,1,Journal,2-s2.0-67650837935
Janeway K.,,Sunitinib treatment in pediatric patients with advanced GIST following failure of imatinib,2009,Pediatric Blood and Cancer,105,10.1002/pbc.21909,United States,Article,Boston,0,Journal,2-s2.0-67650472798
Agaimy A.,,V600E BRAF mutations are alternative early molecular events in a subset of KIT/PDGFRA wildtype gastrointestinal stromal tumours,2009,Journal of Clinical Pathology,144,10.1136/jcp.2009.064550,Germany;Germany,Article,Erlangen;Erlangen,0,Journal,2-s2.0-67650480850
Romeo S.,,Cell cycle/apoptosis molecule expression correlates with imatinib response in patients with advanced gastrointestinal stromal tumors,2009,Clinical Cancer Research,53,10.1158/1078-0432.CCR-08-3297,Netherlands,Article,Leiden,1,Journal,2-s2.0-67449168370
Liegl B.,,"Monoclonal antibody DOG1.1 Shows higher sensitivity than KIT in the diagnosis of gastrointestinal stromal tumors, including unusual subtypes",2009,American Journal of Surgical Pathology,195,10.1097/PAS.0b013e318186b158,Austria;United States,Article,Graz;Boston,0,Journal,2-s2.0-62849083680
Liegl B.,,Rhabdomyosarcomatous differentiation in gastrointestinal stromal tumors after tyrosine kinase inhibitor Therapy: A novel form of tumor progression,2009,American Journal of Surgical Pathology,53,10.1097/PAS.0b013e31817ec2e6,United States;Austria,Article,Boston;Graz,0,Journal,2-s2.0-60249088620
DeMatteo R.,,"Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial",20090328/0403,The Lancet,936,10.1016/S0140-6736(09)60500-6,United States,Article,New York,0,Journal,2-s2.0-62849096370
Heinrich M.,,Correlation of kinase genotype and clinical outcome in the North American intergroup phase III trial of imatinib mesylate for treatment of advanced gastrointestinal stromal tumor: CALGB 150105 study by cancer and leukemia group B and southwest oncology group,2008,Journal of Clinical Oncology,423,10.1200/JCO.2008.17.4284,United States,Article,Portland,0,Journal,2-s2.0-56749156604
Heinrich M.C.,,Primary and secondary kinase genotypes correlate with the biological and clinical activity of sunitinib in imatinib-resistant gastrointestinal stromal tumor,2008,Journal of Clinical Oncology,500,10.1200/JCO.2007.15.7461,United States,Article,San Diego,0,Journal,2-s2.0-56749098278
Agaimy A.,,Multiple sporadic gastrointestinal stromal tumors (GISTs) of the proximal stomach are caused by different somatic KIT mutations suggesting a field effect,2008,American Journal of Surgical Pathology,42,10.1097/PAS.0b013e31817587ea,Germany;Germany,Article,Nurnberg;Nurnberg,0,Journal,2-s2.0-53449088979
Schildhaus H.,,Inflammatory fibroid polyps harbour mutations in the platelet-derived growth factor receptor alpha (PDGFRA) gene,2008,Journal of Pathology,98,10.1002/path.2393,Germany,Article,Bonn,0,Journal,2-s2.0-53149140625
Agaram N.,,Novel V600E BRAF mutations in imatinib-naive and imatinib-resistant gastrointestinal stromal tumors,2008,Genes Chromosomes and Cancer,257,10.1002/gcc.20589,United States,Article,New York,0,Journal,2-s2.0-50249152932
Joensuu H.,,Risk stratification of patients diagnosed with gastrointestinal stromal tumor,2008,Human Pathology,609,10.1016/j.humpath.2008.06.025,Finland,Article,Helsinki,0,Journal,2-s2.0-50649085726
Ou W.,,Protein kinase C-θ regulates KIT expression and proliferation in gastrointestinal stromal tumors,2008,Oncogene,61,10.1038/onc.2008.177,United States,Article,Boston,1,Journal,2-s2.0-52149094786
Dewaele B.,,"Activity of dasatinib, a dual SRC/ABL kinase inhibitor, and IPI-504, a heat shock protein 90 inhibitor, against gastrointestinal stromal tumor-associated PDGFRA<sup>D842V</sup> mutation",2008,Clinical Cancer Research,85,10.1158/1078-0432.CCR-08-0533,,Article,,1,Journal,2-s2.0-53249152139
Liegl B.,,Heterogeneity of kinase inhibitor resistance mechanisms in GIST,2008,Journal of Pathology,276,10.1002/path.2382,United States;Austria,Article,Boston;Graz,0,Journal,2-s2.0-50249092801
Lasota J.,,Clinical significance of oncogenic KIT and PDGFRA mutations in gastrointestinal stromal tumours,2008,Histopathology,319,10.1111/j.1365-2559.2008.02977.x,United States,Review,"Washington, D.C.",0,Journal,2-s2.0-49749122255
Tarn C.,,Insulin-like growth factor 1 receptor is a potential therapeutic target for gastrointestinal stromal tumors,2008,Proceedings of the National Academy of Sciences of the United States of America,194,10.1073/pnas.0803383105,United States,Article,Philadelphia,1,Journal,2-s2.0-46149104384
Lyle P.L.,,Gastrointestinal melanoma or clear cell sarcoma? Molecular evaluation of 7 cases previously diagnosed as malignant melanoma,2008,American Journal of Surgical Pathology,51,10.1097/PAS.0b013e31815b8288,United States,Article,Colorado Springs,0,Journal,2-s2.0-46249117064
Lee H.E.,,Characteristics of KIT-negative gastrointestinal stromal tumours and diagnostic utility of protein kinase C theta immunostaining,2008,Journal of Clinical Pathology,52,10.1136/jcp.2007.052225,South Korea,Article,Seoul,0,Journal,2-s2.0-45549090311
Miselli F.,,PDGFRA immunostaining can help in the diagnosis of gastrointestinal stromal tumors,2008,American Journal of Surgical Pathology,34,10.1097/PAS.0b013e31815c47e8,Italy,Article,Milan,0,Journal,2-s2.0-42649117800
Casali P.,,"Gastrointestinal stromal tumors: ESMO clinical recommendations for diagnosis, treatment and follow-up",2008,Annals of Oncology,123,10.1093/annonc/mdn080,Switzerland;Italy,Article,Viganello;Milan,1,Journal,2-s2.0-45149093253
Corless C.,,Molecular pathobiology of gastrointestinal stromal sarcomas,2008,Annual Review of Pathology: Mechanisms of Disease,253,10.1146/annurev.pathmechdis.3.121806.151538,United States,Review,Portland,0,Book Series,2-s2.0-41749118496
Yang X.,,Nestin expression in different tumours and its relevance to malignant grade,2008,Journal of Clinical Pathology,68,10.1136/jcp.2007.047605,China,Article,Guangzhou,1,Journal,2-s2.0-42049087842
Lasota J.,,Clinicopathologic profile of gastrointestinal stromal tumors (GISTs) with primary KIT exon 13 or exon 17 mutations: A multicenter study on 54 cases,2008,Modern Pathology,117,10.1038/modpathol.2008.2,United States,Article,"Washington, D.C.",1,Journal,2-s2.0-41149170835
Kleinbaum E.P.,,"Clinical, histopathologic, molecular and therapeutic findings in a large kindred with gastrointestinal stromal tumor",2008,International Journal of Cancer,49,10.1002/ijc.23137,United States,Article,Houston,1,Journal,2-s2.0-37349043267
Espinosa I.,,A novel monoclonal antibody against DOG1 is a sensitive and specific marker for gastrointestinal stromal tumors,2008,American Journal of Surgical Pathology,313,10.1097/PAS.0b013e3181238cec,United States,Article,Stanford,0,Journal,2-s2.0-38649098794
Blanke C.,,Long-term results from a randomized phase II trial of standard- versus higher-dose imatinib mesylate for patients with unresectable or metastatic gastrointestinal stromal tumors expressing KIT,2008,Journal of Clinical Oncology,723,10.1200/JCO.2007.13.4403,Finland,Article,Helsinki,0,Journal,2-s2.0-39149123549
Blanke C.D.,,"Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033",2008,Journal of Clinical Oncology,746,10.1200/JCO.2007.13.4452,United States,Article,Portland,0,Journal,2-s2.0-39149127634
Steigen S.,,Diagnostic and prognostic markers for gastrointestinal stromal tumors in Norway,2008,Modern Pathology,39,10.1038/modpathol.3800976,Norway,Article,Tromso,1,Journal,2-s2.0-37549051775
Pasini B.,,"Clinical and molecular genetics of patients with the Carney-Stratakis syndrome and germline mutations of the genes coding for the succinate dehydrogenase subunits SDHB, SDHC, and SDHD",2008,European Journal of Human Genetics,324,10.1038/sj.ejhg.5201904,Italy,Article,Turin,1,Journal,2-s2.0-37349074531
Zheng S.,,Analysis of mutation and expression of c-kit and PDGFR-α gene in gastrointestinal stromal tumor,2007,Hepato-Gastroenterology,26,,China,Article,Hangzhou,0,Journal,2-s2.0-37749010253
Bauer S.,,KIT oncogenic signaling mechanisms in imatinib-resistant gastrointestinal stromal tumor: PI3-kinase/AKT is a crucial survival pathway,2007,Oncogene,182,10.1038/sj.onc.1210558,United States,Article,Boston,1,Journal,2-s2.0-36749030022
Abraham S.,,"""Seedling"" mesenchymal tumors (gastrointestinal stromal tumors and leiomyomas) are common incidental tumors of the esophagogastric junction",2007,American Journal of Surgical Pathology,90,10.1097/PAS.0b013e31806ab2c3,United States,Article,Rochester,0,Journal,2-s2.0-37349127785
Lasota J.,,Presence of homozygous KIT exon 11 mutations is strongly associated with malignant clinical behavior in gastrointestinal stromal tumors,2007,Laboratory Investigation,67,10.1038/labinvest.3700628,United States,Article,"Washington, D.C.",1,Journal,2-s2.0-34548788543
Janeway K.A.,,Pediatric KIT-wild-type and platelet-derived growth factor receptor α-wild-type gastrointestinal stromal tumors share KIT activation but not mechanisms of genetic progression with adult gastrointestinal stromal tumors,2007,Cancer Research,123,10.1158/0008-5472.CAN-07-1938,United States;United States;United States,Article,Boston;Boston;Boston,1,Journal,2-s2.0-35148813515
Carlson J.,,Immunohistochemistry for β-catenin in the differential diagnosis of spindle cell lesions: Analysis of a series and review of the literature,2007,Histopathology,172,10.1111/j.1365-2559.2007.02794.x,United States,Article,Boston,0,Journal,2-s2.0-34548777536
Demetri G.D.,,NCCN task force report: Management of patients with Gastrointestinal Stromal Tumor (GIST) - Update of the NCCN clinical practice guidelines,2007,JNCCN Journal of the National Comprehensive Cancer Network,458,,United States,Review,Boston,0,Journal,2-s2.0-34447557780
Hornick J.,,The role of KIT in the management of patients with gastrointestinal stromal tumors,2007,Human Pathology,151,10.1016/j.humpath.2007.03.001,United States;United States,Review,Boston;Boston,0,Journal,2-s2.0-34147103980
Price N.,,Highly accurate two-gene classifier for differentiating gastrointestinal stromal tumors and leiomyosarcomas,2007,Proceedings of the National Academy of Sciences of the United States of America,126,10.1073/pnas.0611373104,United States,Article,Seattle,1,Journal,2-s2.0-33847665105
Kang D.,,Multiple gastrointestinal stromal tumors: Clinicopathologic and genetic analysis of 12 patients,2007,American Journal of Surgical Pathology,84,10.1097/01.pas.0000213318.66800.94,South Korea,Article,Daejeon,0,Journal,2-s2.0-33846567566
Agaram N.,,Pathologic and molecular heterogeneity in imatinib-stable or imatinib-responsive gastrointestinal stromal tumors,2007,Clinical Cancer Research,93,10.1158/1078-0432.CCR-06-1508,United States,Article,New York,1,Journal,2-s2.0-33846277973
Agaimy A.,,Minute Gastric Sclerosing Stromal Tumors (GIST Tumorlets) are common in adults and frequently show c-KIT mutations,2007,American Journal of Surgical Pathology,255,10.1097/01.pas.0000213307.05811.f0,Germany;Germany,Article,Nurnberg;Nurnberg,0,Journal,2-s2.0-33845940073
Nemoto Y.,,Correlation of enhanced cell turnover with prognosis of gastrointestinal stromal tumors of the stomach: Relevance of cellularity and p27<sup>Kip1</sup>,2006,Pathology International,20,10.1111/j.1440-1827.2006.02038.x,Japan;Japan,Article,Tokyo;Sagamihara,0,Journal,2-s2.0-33750618580
Peterson M.,,Strong PDGFRA positivity is seen in GISTs but not in other intra-abdominal mesenchymal tumors: Immunohistochemical and mutational analyses,2006,Applied Immunohistochemistry and Molecular Morphology,28,10.1097/01.pai.0000203038.33414.a3,United States,Article,San Diego,0,Journal,2-s2.0-33751364089
Kawanowa K.,,High incidence of microscopic gastrointestinal stromal tumors in the stomach,2006,Human Pathology,252,10.1016/j.humpath.2006.07.002,Japan;Japan,Article,Tokyo;Kitaadachi District,0,Journal,2-s2.0-33751225088
Demetri G.,,Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial,2006,Lancet,1884,10.1016/S0140-6736(06)69446-4,United States,Article,Boston,0,Journal,2-s2.0-33749505836
Heinrich M.,,Molecular correlates of imatinib resistance in gastrointestinal stromal tumors,2006,Journal of Clinical Oncology,613,10.1200/JCO.2006.06.2265,,Article,,0,Journal,2-s2.0-33750595859
Antonescu C.R.,,EWS-CREB1: A recurrent variant fusion in clear cell sarcoma - Association with gastrointestinal location and absence of melanocytic differentiation,2006,Clinical Cancer Research,199,10.1158/1078-0432.CCR-05-2811,United States,Article,New York,1,Journal,2-s2.0-33749334696
Bauer S.,,Heat shock protein 90 inhibition in imatinib-resistant gastrointestinal stromal tumor,2006,Cancer Research,202,10.1158/0008-5472.CAN-06-0165,United States;Germany,Article,Boston;Essen,1,Journal,2-s2.0-33749461709
Schurr P.,,Microsatellite DNA alterations of gastrointestinal stromal tumors are predictive for outcome,2006,Clinical Cancer Research,17,10.1158/1078-0432.CCR-05-2083,Germany,Article,Hamburg,1,Journal,2-s2.0-33749036310
Rossi F.,,Oncogenic Kit signaling and therapeutic intervention in a mouse model of gastrointestinal stromal tumor,2006,Proceedings of the National Academy of Sciences of the United States of America,92,10.1073/pnas.0511076103,United States,Article,New York,1,Journal,2-s2.0-33748059560
Sambol E.,,Flavopiridol targets c-KIT transcription and induces apoptosis in gastrointestinal stromal tumor cells,2006,Cancer Research,73,10.1158/0008-5472.CAN-05-2933,United States,Article,New York,1,Journal,2-s2.0-33745259006
Lasota J.,,KIT and PDGFRA mutations in gastrointestinal stromal tumors (GISTs),2006,Seminars in Diagnostic Pathology,210,10.1053/j.semdp.2006.08.006,United States,Article,"Washington, D.C.",0,Journal,2-s2.0-33750623679
Debiec-Rychter M.,,KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours,2006,European Journal of Cancer,668,10.1016/j.ejca.2006.01.030,Belgium,Article,3000 Leuven,0,Journal,2-s2.0-33746401591
Miettinen M.,,Gastrointestinal stromal tumors: Pathology and prognosis at different sites,2006,Seminars in Diagnostic Pathology,1157,10.1053/j.semdp.2006.09.001,United States,Article,"Washington, D.C.",0,Journal,2-s2.0-33750618188
Prenen H.,,Efficacy of the kinase inhibitor SU11248 against gastrointestinal stromal tumor mutants refractory to imatinib mesylate,2006,Clinical Cancer Research,234,10.1158/1078-0432.CCR-05-2275,Belgium,Article,Ghent,1,Journal,2-s2.0-33646432734
Miettinen M.,,"Gastrointestinal stromal tumors of the jejunum and ileum: A clinicopathologic, immunohistochemical, and molecular genetic study of 906 cases before imatinib with long-term follow-up",2006,American Journal of Surgical Pathology,457,10.1097/00000478-200604000-00008,United States,Article,"Washington, D.C.",0,Journal,2-s2.0-33646685694
Wardelmann E.,,Polyclonal evolution of multiple secondary KIT mutations in gastrointestinal stromal tumors under treatment with imatinib mesylate,2006,Clinical Cancer Research,274,10.1158/1078-0432.CCR-05-1211,Germany,Article,Bonn,1,Journal,2-s2.0-33645693156
Maertens O.,,Molecular pathogenesis of multiple gastrointestinal stromal tumors in NF1 patients,2006,Human Molecular Genetics,169,10.1093/hmg/ddl016,Belgium,Article,Ghent,1,Journal,2-s2.0-33644781795
Lasota J.,,GISTs with PDGFRA exon 14 mutations represent subset of clinically favorable gastric tumors with epithelioid morphology,2006,Laboratory Investigation,115,10.1038/labinvest.3700360,United States,Article,"Washington, D.C.",1,Journal,2-s2.0-32844458682
Miettinen M.,,Gastrointestinal stromal tumors in patients with neurofibromatosis 1: A clinicopathologic and molecular genetic study of 45 cases,2006,American Journal of Surgical Pathology,319,10.1097/01.pas.0000176433.81079.bd,United States,Article,"Washington, D.C.",0,Journal,2-s2.0-33644752349
Goettsch W.,,Incidence of gastrointestinal stromal tumours is underestimated: Results of a nation-wide study,2005,European Journal of Cancer,234,10.1016/j.ejca.2005.09.009,Netherlands,Article,Utrecht,0,Journal,2-s2.0-28244441991
Corless C.,,"PDGFRA mutations in gastrointestinal stromal tumors: Frequency, spectrum and in vitro sensitivity to imatinib",2005,Journal of Clinical Oncology,587,10.1200/JCO.2005.14.068,,Article,,0,Journal,2-s2.0-23944476156
Tryggvason G.,,"Gastrointestinal stromal tumors in Iceland, 1990-2003: The Icelandic GIST study, a population-based incidence and pathologic risk stratification study",2005,International Journal of Cancer,261,10.1002/ijc.21167,Iceland,Article,Reykjavik,1,Journal,2-s2.0-25444448316
Miettinen M.,,"Gastrointestinal stromal tumors of the stomach in children and young adults: A clinicopathologic, immunohistochemical, and molecular genetic study of 44 cases with long-term follow-up and review of the literature",2005,American Journal of Surgical Pathology,223,10.1097/01.pas.0000172190.79552.8b,United States,Review,"Washington, D.C.",0,Journal,2-s2.0-25444494428
Andersson J.,,"NF1-associated gastrointestinal stromal tumors have unique clinical, phenotypic, and genotypic characteristics",2005,American Journal of Surgical Pathology,191,10.1097/01.pas.0000159775.77912.15,Sweden,Article,Gothenburg,0,Journal,2-s2.0-24144477000
Miettinen M.,,"KIT (CD117): A review on expression in normal and neoplastic tissues, and mutations and their clinicopathologic correlation",2005,Applied Immunohistochemistry and Molecular Morphology,373,10.1097/01.pai.0000173054.83414.22,United States,Review,"Washington, D.C.",0,Journal,2-s2.0-23944452835
Perrone F.,,9p21 locus analysis in high-risk gastrointestinal stromal tumors characterized for c-kit and platelet-derived growth factor receptor α gene alterations,2005,Cancer,51,10.1002/cncr.21113,Italy,Article,Milan,1,Journal,2-s2.0-20544445201
Tornillo L.,,Patterns of gene amplification in gastrointestinal stromal tumors (GIST),2005,Laboratory Investigation,54,10.1038/labinvest.3700284,Switzerland,Article,Basel,1,Journal,2-s2.0-22544452099
Pauwels P.,,Changing phenotype of gastrointestinal stromal tumours under imatinib mesylate treatment: A potential diagnostic pitfall,2005,Histopathology,68,10.1111/j.1365-2559.2005.02179.x,Netherlands,Article,Maastricht,0,Journal,2-s2.0-22144464484
Antonescu C.,,Acquired resistance to imatinib in gastrointestinal stromal tumor occurs through secondary gene mutation,2005,Clinical Cancer Research,619,10.1158/1078-0432.CCR-04-2245,United States,Article,New York,1,Journal,2-s2.0-20344393896
Rossi G.,,PDGFR expression in differential diagnosis between KIT-negative gastrointestinal stromal tumours and other primary soft-tissue tumours of the gastrointestinal tract,2005,Histopathology,61,10.1111/j.1365-2559.2005.02128.x,Italy,Article,Modena,0,Journal,2-s2.0-20944446788
Li F.P.,,Familial gastrointestinal stromal tumor syndrome: Phenotypic and molecular features in a kindred,2005,Journal of Clinical Oncology,123,10.1200/JCO.2005.06.009,United States,Article,,0,Journal,2-s2.0-21044439344
Prakash S.,,"Gastrointestinal stromal tumors in children and young adults: A clinicopathologic, molecular, and genomic study of 15 cases and review of the literature",2005,Journal of Pediatric Hematology/Oncology,208,10.1097/01.mph.0000157790.81329.47,United States,Conference Paper,New York,0,Journal,2-s2.0-20944442418
Feakins R.M.,,"The expression of p53 and bcl-2 in gastrointestinal stromal tumours is associated with anatomical site, and p53 expression is associated with grade and clinical outcome",2005,Histopathology,50,10.1111/j.1365-2559.2005.02071.x,United Kingdom;United Kingdom,Article,London;London,0,Journal,2-s2.0-14844314779
Nilsson B.,,"Gastrointestinal stromal tumors: The incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era - A population-based study in western Sweden",2005,Cancer,904,10.1002/cncr.20862,Sweden,Review,Gothenburg,0,Journal,2-s2.0-13444270334
Schneider-Stock R.,,Loss of p16 protein defines high-risk patients with gastrointestinal stromal tumors: A tissue microarray study,2005,Clinical Cancer Research,109,,Germany,Article,Magdeburg,0,Journal,2-s2.0-19944427609
Orosz Z.,,Gastrointestinal stromal tumors: A clinicopathologic and immunohistochemical study of 136 cases,2005,Pathology and Oncology Research,58,10.1007/BF03032400,Hungary,Article,Budapest,0,Journal,2-s2.0-18444385858
O'Riain C.,,Gastrointestinal stromal tumors: Insights from a new familial GIST kindred with unusual genetic and pathologic features,2005,American Journal of Surgical Pathology,63,10.1097/01.pas.0000173024.79852.08,Ireland,Conference Paper,Dublin,0,Journal,2-s2.0-33644812236
Debiec-Rychter M.,,Mechanisms of resistance to imatinib mesylate in gastrointestinal stromal tumors and activity of the PKC412 inhibitor against imatinib-resistant mutants,2005,Gastroenterology,410,10.1053/j.gastro.2004.11.020,Belgium,Article,3000 Leuven,0,Journal,2-s2.0-14944352767
Miettinen M.,,"Gastrointestinal stromal tumors of the stomach: A clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up",2005,American Journal of Surgical Pathology,938,10.1097/01.pas.0000146010.92933.de,United States,Article,"Washington, D.C.",0,Journal,2-s2.0-11144284051
Corless C.,,Biology of gastrointestinal stromal tumors,2004,Journal of Clinical Oncology,937,10.1200/JCO.2004.05.140,United States,Review,Boston,0,Journal,2-s2.0-4644312266
Sabah M.,,Loss of heterozygosity of chromosome 9p and loss of p16<sup>INK4A</sup> expression are associated with malignant gastrointestinal stromal tumors,2004,Modern Pathology,53,10.1038/modpathol.3800199,Ireland,Article,Dublin,1,Journal,2-s2.0-8144222050
Duensing A.,,Protein kinase C θ (PKC θ) expression and constitutive activation in gastrointestinal stromal tumors (GISTs),2004,Cancer Research,106,10.1158/0008-5472.CAN-04-0559,United States;United States,Article,Pittsburgh;Boston,0,Journal,2-s2.0-3442881363
Blay P.,,Protein kinase C θ is highly expressed in gastrointestinal stromal tumors but not in other mesenchymal neoplasias,2004,Clinical Cancer Research,127,10.1158/1078-0432.CCR-04-0630,Spain,Article,Oviedo,1,Journal,2-s2.0-3042538269
Lasota J.,,A great majority of GISTs with PDGFRA mutations represent gastric tumors of low or no malignant potential,2004,Laboratory Investigation,236,10.1038/labinvest.3700122,United States,Article,"Washington, D.C.",1,Journal,2-s2.0-3042646931
Medeiros F.,,KIT-negative gastrointestinal stromal tumors: Proof of concept and therapeutic implications,2004,American Journal of Surgical Pathology,382,10.1097/00000478-200407000-00007,United States,Article,Boston,0,Journal,2-s2.0-2142747025
Hubbard S.,,Juxtamembrane autoinhibition in receptor tyrosine kinases,2004,Nature Reviews Molecular Cell Biology,209,10.1038/nrm1399,United States,Review,New York,0,Journal,2-s2.0-2942594298
Duensing A.,,Mechanisms of oncogenic KIT signal transduction in primary gastrointestinal stromal tumors (GISTs),2004,Oncogene,256,10.1038/sj.onc.1207525,United States;United States,Article,Pittsburgh;Boston,1,Journal,2-s2.0-2542520755
Debiec-Rychter M.,,Gastrointestinal stromal tumours (GISTs) negative for KIT (CD117 antigen) immunoreactivity,2004,Journal of Pathology,171,10.1002/path.1546,Belgium;Belgium,Article,Leuven;3000 Leuven,0,Journal,2-s2.0-1842426806
Ricci R.,,Role of p16/INK4a in gastrointestinal stromal tumor progression,2004,American Journal of Clinical Pathology,54,10.1309/MJ4XN2M57HNC8X5H,Italy,Article,Rome,1,Journal,2-s2.0-3042723785
Wardelmann E.,,Association of platelet-derived growth factor receptor α mutations with gastric primary site and epithelioid or mixed cell morphology in gastrointestinal stromal tumors,2004,Journal of Molecular Diagnostics,137,10.1016/S1525-1578(10)60510-7,Germany,Article,Bonn,0,Journal,2-s2.0-4344611744
West R.B.,,"The novel marker, DOG1, is expressed ubiquitously in gastrointestinal stromal tumors irrespective of KIT or PDGFRA mutation status",2004,American Journal of Pathology,456,10.1016/S0002-9440(10)63279-8,United States,Article,Stanford,0,Journal,2-s2.0-3042594995
Lasota J.,,Gastrointestinal Stromal Tumors with Internal Tandem Duplications in 3′ End of KIT Juxtamembrane Domain Occur Predominantly in Stomach and Generally Seem to Have a Favorable Course,2003,Modern Pathology,91,10.1097/01.MP.0000097365.72526.3E,United States,Article,"Washington, D.C.",1,Journal,2-s2.0-0346362402
Heinrich M.,,Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor,2003,Journal of Clinical Oncology,1796,10.1200/JCO.2003.04.190,,Article,,0,Journal,2-s2.0-0642368571
Wardelmann E.,,Deletion of Trp-557 and Lys-558 in the juxtamembrane domain of the c-kit protooncogene is associated with metastatic behavior of gastrointestinal stromal tumors,2003,International Journal of Cancer,194,10.1002/ijc.11323,Germany;Germany,Article,Bonn;Bonn,1,Journal,2-s2.0-0042338788
Pruneri G.,,Cyclin D3 immunoreactivity in gastrointestinal stromal tumors is independent of cyclin D3 gene amplification and is associated with nuclear p27 accumulation,2003,Modern Pathology,24,10.1097/01.MP.0000085026.38856.B9,Italy,Article,Milan,1,Journal,2-s2.0-0141519092
Antonescu C.,,Association of KIT exon 9 mutations with nongastric primary site and aggressive behavior: KIT mutation analysis and clinical correlates of 120 gastrointestinal stromal tumors,2003,Clinical Cancer Research,299,,United States,Article,New York,0,Journal,2-s2.0-10744225271
Hirota S.,,Gain-of-function mutations of platelet-derived growth factor receptor α gene in gastrointestinal stromal tumors,2003,Gastroenterology,574,10.1016/S0016-5085(03)01046-1,Japan,Article,Suita,0,Journal,2-s2.0-0041971080
Casteran N.,,Signal transduction by several KIT juxtamembrane domain mutations,2003,Oncogene,62,10.1038/sj.onc.1206587,France,Article,Paris,0,Journal,2-s2.0-0042090223
Schneider-Stock R.,,High prognostic value of p16<sup>INK4</sup> alterations in gastrointestinal stromal tumors,2003,Journal of Clinical Oncology,138,10.1200/JCO.2003.08.101,Germany,Article,Magdeburg,0,Journal,2-s2.0-0038135029
O'Farrell A.,,SU11248 is a novel FLT3 tyrosine kinase inhibitor with potent activity in vitro and in vivo,2003,Blood,737,10.1182/blood-2002-07-2307,United States,Article,San Francisco,0,Journal,2-s2.0-0038204144
Lucas D.,,c-Kit expression in desmoid fibromatosis: Comparative immunohistochemical evaluation of two commercial antibodies,2003,American Journal of Clinical Pathology,85,10.1309/AN4E2ETCJ4R6JJUY,United States;United States,Article,Detroit;Detroit,1,Journal,2-s2.0-0037365824
Heinrich M.C.,,PDGFRA activating mutations in gastrointestinal stromal tumors,2003,Science,1808,10.1126/science.1079666,United States,Article,Portland,0,Journal,2-s2.0-0242670019
Mendel D.,,"In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors: Determination of a pharmacokinetic/pharmacodynamic relationship",2003,Clinical Cancer Research,1730,,United States,Article,San Francisco,0,Journal,2-s2.0-12244301581
Edmonson J.,,"Contrast of response to dacarbazine, mitomycin, doxorubicin, and cisplatin (DMAP) plus GM-CSF between patients with advanced malignant gastrointestinal stromal tumors and patients with other advanced leiomyosarcomas",2002,Cancer Investigation,94,10.1081/CNV-120002485,United States,Article,Rochester,0,Journal,2-s2.0-0036049018
Montgomery E.,,β-Catenin immunohistochemistry separates mesenteric fibromatosis from gastrointestinal stromal tumor and sclerosing mesenteritis,2002,American Journal of Surgical Pathology,153,10.1097/00000478-200210000-00006,United States,Article,Baltimore,0,Journal,2-s2.0-0036787409
Hornick J.,,Immunohistochemical staining for KIT (CD117) in soft tissue sarcomas is very limited in distribution,2002,American Journal of Clinical Pathology,260,10.1309/LX9U-F7P0-UWDH-8Y6R,United States,Article,Boston,1,Journal,2-s2.0-0036319991
Carney J.,,Familial paraganglioma and gastric stromal sarcoma: A new syndrome distinct from the Carney triad,2002,American Journal of Medical Genetics,233,10.1002/ajmg.10235,United States,Article,Rochester,0,Journal,2-s2.0-0036499042
Pawson T.,,Regulation and targets of receptor tyrosine kinases.,2002,"European journal of cancer (Oxford, England : 1990)",202,10.1016/s0959-8049(02)80597-4,Canada,Review,Toronto,0,Journal,2-s2.0-0036769119
Cessna M.H.,,Expression of ALK1 and p80 in inflammatory myofibroblastic tumor and its mesenchymal mimics: A study of 135 cases,2002,Modern Pathology,272,10.1097/01.MP.0000026615.04130.1F,United States,Article,Salt Lake City,1,Journal,2-s2.0-0036734911
Fletcher C.,,Diagnosis of gastrointestinal stromal tumors: A consensus approach,2002,International Journal of Surgical Pathology,302,10.1177/106689690201000201,United States,Article,Boston,0,Journal,2-s2.0-0036081738
Corless C.L.,,KIT mutations are common in incidental gastrointestinal stromal tumors one centimeter or less in size,2002,American Journal of Pathology,381,10.1016/S0002-9440(10)61103-0,United States;United States,Article,Portland;Portland,0,Journal,2-s2.0-0036092268
Fletcher C.,,Diagnosis of gastrointestinal stromal tumors: A consensus approach,2002,Human Pathology,2592,10.1053/hupa.2002.123545,United States;United States;United States;United States;United States;United States;United States;United States;United States,Article,"Seattle;Atlanta;Portland;Philadelphia;Bethesda;New York;Boston;Washington, D.C.;Bethesda",0,Journal,2-s2.0-0036301722
Rubin B.,,KIT activation is a ubiquitous feature of gastrointestinal stromal tumors,2001,Cancer Research,837,,United States,Article,Boston,0,Journal,2-s2.0-0035890740
Beghini A.,,Germline mutation in the juxtamembrane domain of the kit gene in a family with gastrointestinal stromal tumors and urticaria pigmentosa,2001,Cancer,183,10.1002/1097-0142(20010801)92:3<657::AID-CNCR1367>3.0.CO;2-D,Italy;Italy;Italy,Article,Milan;Varese;Varese,1,Journal,2-s2.0-0035425217
Debiec-Rychter M.,,Chromosomal aberrations in malignant gastrointestinal stromal tumorscorrelation with c-KIT gene mutation,2001,Cancer Genetics and Cytogenetics,104,10.1016/S0165-4608(01)00395-8,United States,Article,"Washington, D.C.",0,Journal,2-s2.0-0035397627
Maeyama H.,,Familial gastrointestinal stromal tumor with hyperpigmentation: Association with a germline mutation of the c-kit gene,2001,Gastroenterology,199,10.1053/gast.2001.20880,Japan,Article,Nagano,0,Journal,2-s2.0-0035174752
El-Rifai W.,,High-resolution deletion mapping of chromosome 14 in stromal tumors of the gastrointestinal tract suggests two distinct tumor suppressor loci,2000,Genes Chromosomes and Cancer,73,10.1002/(SICI)1098-2264(200004)27:4<387::AID-GCC8>3.0.CO;2-C,Finland;Egypt,Article,Helsinki;Cairo,0,Journal,2-s2.0-0034006759
Kim N.,,"Putative chromosomal deletions on 9p, 9q and 22q occur preferentially in malignant gastrointestinal stromal tumors",2000,International Journal of Cancer,86,10.1002/(SICI)1097-0215(20000301)85:5<633::AID-IJC6>3.0.CO;2-5,South Korea,Article,Seoul,1,Journal,2-s2.0-0033980085
Fukasawa T.,,"Allelic loss of 14q and 22q, NF2 mutation, and genetic instability occur independently of c-kit mutation in gastrointestinal stromal tumor",2000,Japanese Journal of Cancer Research,72,10.1111/j.1349-7006.2000.tb00910.x,Japan;Japan,Article,Kawachi District;Kofu,1,Journal,2-s2.0-0034525682
Robinson T.,,Gastrointestinal stromal tumors may originate from a subset of CD34-positive interstitial cells of Cajal,2000,American Journal of Pathology,156,10.1016/S0002-9440(10)64984-X,Canada,Article,Hamilton,0,Journal,2-s2.0-0033847535
Isozaki K.,,Germline-activating mutation in the kinase domain of KIT gene in familial gastrointestinal stromal tumors,2000,American Journal of Pathology,211,10.1016/S0002-9440(10)64795-5,Belgium,Article,Brussels,0,Journal,2-s2.0-0033678402
Reith J.D.,,Extragastrointestinal (soft tissue) stromal tumors: An analysis of 48 cases with emphasis on histologic predictors of outcome,2000,Modern Pathology,381,10.1038/modpathol.3880099,United States,Article,Gainesville,1,Journal,2-s2.0-0034109008
DeMatteo R.,,Two hundred gastrointestinal stromal tumors: Recurrence patterns and prognostic factors for survival,2000,Annals of Surgery,1988,10.1097/00000658-200001000-00008,United States,Article,New York,0,Journal,2-s2.0-0033984319
Miettinen M.,,Gastrointestinal stromal tumors/smooth muscle tumors (GISTs) primary in the omentum and mesentery: Clinicopathologic and immunohistochemical study of 26 cases,1999,American Journal of Surgical Pathology,447,10.1097/00000478-199909000-00015,United States,Article,"Washington, D.C.",0,Journal,2-s2.0-0032862462
Ma Y.,,Inhibition of spontaneous receptor phosphorylation by residues in a putative α-helix in the KIT intracellular juxtamembrane region,1999,Journal of Biological Chemistry,99,10.1074/jbc.274.19.13399,United States,Article,New York,1,Journal,2-s2.0-0033532190
Aidan Carney J.,,"Gastric stromal sarcoma, pulmonary chondroma, and extra-adrenal paraganglioma (Carney triad): Natural history, adrenocortical component, and possible familial occurrence",1999,Mayo Clinic Proceedings,331,10.4065/74.6.543,United States,Article,Rochester,0,Journal,2-s2.0-0033064974
Nishida T.,,Familial gastrointestinal stromal tumours with germline mutation of the KIT gene [3],1998,Nature Genetics,474,10.1038/1209,Japan,Letter,Suita,0,Journal,2-s2.0-0031848146
Sarlomo-Rikala M.,,CD117: A sensitive marker for gastrointestinal stromal tumors that is more specific than CD34,1998,Modern Pathology,683,,Finland,Article,Helsinki,0,Journal,2-s2.0-0031857113
Kindblom L.,,Gastrointestinal pacemaker cell tumor (GIPACT): Gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal,1998,American Journal of Pathology,1358,,Sweden,Article,Gothenburg,0,Journal,2-s2.0-0031947592
Hirota S.,,Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors,1998,Science,3514,10.1126/science.279.5350.577,,Article,,0,Journal,2-s2.0-15644363454
Bergmann F.,,Cytogenetic and morphologic characteristics of gastrointestinal stromal tumors. Recurrent rearrangement of chromosome 1 and losses of chromosomes 14 and 22 as common anomalies.,1998,Verhandlungen der Deutschen Gesellschaft für Pathologie,34,,Germany,Article,Aachen,0,Journal,2-s2.0-0032248622
El-Rifai W.,,DNA copy number losses in chromosome 14: An early change in gastrointestinal stromal tumors,1996,Cancer Research,120,,Egypt;Finland,Article,Cairo;Helsinki,0,Journal,2-s2.0-0029900130
Kitayama H.,,Constitutively activating mutations of c-kit receptor tyrosine kinase confer factor-independent growth and tumorigenicity of factor-dependent hematopoietic cell lines,1995,Blood,232,10.1182/blood.v85.3.790.bloodjournal853790,Japan,Article,Suita,1,Journal,2-s2.0-0028959163
Hulzinga J.,,W/kit gene required for interstitial cells of cajal and for intestinal pacemaker activity,1995,Nature,1176,10.1038/373347a0,Canada,Letter,Hamilton,0,Journal,2-s2.0-0028796630
SARLOMO‐RIKALA M.,,Gastric schwannoma—a clinicopathological analysis of six cases,1995,Histopathology,111,10.1111/j.1365-2559.1995.tb01526.x,Finland,Article,Helsinki,0,Journal,2-s2.0-0028824511
Isozaki K.,,"Disturbed intestinal movement, bile reflux to the stomach, and deficiency of c-kit-expressing cells in Ws Ws mutant rats",1995,Gastroenterology,159,10.1016/0016-5085(95)90333-X,Japan,Article,Suita,0,Journal,2-s2.0-0029101721
Miettinen M.,,Gastrointestinal stromal tumors - Value of CD34 antigen in their identification and separation from true leiomyomas and schwannomas,1995,American Journal of Surgical Pathology,489,10.1097/00000478-199502000-00009,United States,Article,Philadelphia,0,Journal,2-s2.0-0028908814
Lev S.,,Interspecies molecular chimeras of kit help define the binding site of the stem cell factor,1993,Molecular and Cellular Biology,67,10.1128/MCB.13.4.2224,Israel,Article,Rehovot,1,Journal,2-s2.0-0027477388
Maeda H.,,Requirement of c-kit for development of intestinal pacemaker system,1992,Development,617,,Japan,Article,Kumamoto,0,Journal,2-s2.0-0026480717
Blume-Jensen P.,,Activation of the human c-kit product by ligand-induced dimerization mediates circular actin reorganization and chemotaxis,1991,EMBO Journal,254,10.1002/j.1460-2075.1991.tb04989.x,Sweden,Article,Uppsala,1,Journal,2-s2.0-0026039464
Stenman G.,,Human PDGFA receptor gene maps to the same region on chromosome 4 as the KIT oncogene,1989,"Genes, Chromosomes and Cancer",26,10.1002/gcc.2870010208,Sweden,Article,Gothenburg,0,Journal,2-s2.0-0024917659
Mazur M.T.,,Gastric stromal tumors. Reappraisal of histogenesis,1983,American Journal of Surgical Pathology,804,10.1097/00000478-198309000-00001,United States,Article,St. Louis,0,Journal,2-s2.0-0020514752
